CN104224739B - 一种以恩替卡韦为主药成分的口服固体组合物 - Google Patents
一种以恩替卡韦为主药成分的口服固体组合物 Download PDFInfo
- Publication number
- CN104224739B CN104224739B CN201410479622.7A CN201410479622A CN104224739B CN 104224739 B CN104224739 B CN 104224739B CN 201410479622 A CN201410479622 A CN 201410479622A CN 104224739 B CN104224739 B CN 104224739B
- Authority
- CN
- China
- Prior art keywords
- entecavir
- gained
- oral solid
- take
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
Description
规格 | 10min | 20min | 30min | 45min | 60min |
0.5mg | 95.2% | 96.4% | 96.5% | 97.2% | 99.4% |
1.0mg | 92.5% | 93.4% | 94.6% | 95.6% | 97.8% |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410479622.7A CN104224739B (zh) | 2014-09-18 | 2014-09-18 | 一种以恩替卡韦为主药成分的口服固体组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410479622.7A CN104224739B (zh) | 2014-09-18 | 2014-09-18 | 一种以恩替卡韦为主药成分的口服固体组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104224739A CN104224739A (zh) | 2014-12-24 |
CN104224739B true CN104224739B (zh) | 2017-02-15 |
Family
ID=52214224
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410479622.7A Active CN104224739B (zh) | 2014-09-18 | 2014-09-18 | 一种以恩替卡韦为主药成分的口服固体组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104224739B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110585148A (zh) * | 2019-09-19 | 2019-12-20 | 苏州扬厉医药科技有限公司 | 一种恩替卡韦片及其制备方法 |
CN113730367B (zh) * | 2021-09-28 | 2022-12-02 | 海南海灵化学制药有限公司 | 一种恩替卡韦片的制备工艺 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101371841A (zh) * | 2007-08-23 | 2009-02-25 | 浙江医药股份有限公司新昌制药厂 | 结晶型恩替卡韦制剂及其制备方法和应用 |
CN102552920A (zh) * | 2012-02-20 | 2012-07-11 | 北京协和药厂 | 一种含恩替卡韦的药物组合物及其制备方法 |
EP2508172A1 (en) * | 2011-04-06 | 2012-10-10 | Zentiva, a.s. | Stable and uniform formulations of entecavir and preparation method thereof |
WO2013114389A1 (en) * | 2011-12-21 | 2013-08-08 | Mylan Laboratories Limited. | Process for preparing solid oral formulations comprising low dose of entecavir |
-
2014
- 2014-09-18 CN CN201410479622.7A patent/CN104224739B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101371841A (zh) * | 2007-08-23 | 2009-02-25 | 浙江医药股份有限公司新昌制药厂 | 结晶型恩替卡韦制剂及其制备方法和应用 |
EP2508172A1 (en) * | 2011-04-06 | 2012-10-10 | Zentiva, a.s. | Stable and uniform formulations of entecavir and preparation method thereof |
WO2013114389A1 (en) * | 2011-12-21 | 2013-08-08 | Mylan Laboratories Limited. | Process for preparing solid oral formulations comprising low dose of entecavir |
CN102552920A (zh) * | 2012-02-20 | 2012-07-11 | 北京协和药厂 | 一种含恩替卡韦的药物组合物及其制备方法 |
Non-Patent Citations (1)
Title |
---|
LC-MS/MS method for the characterization of the forced degradation products of entecavir;Thippani Ramesh 等;《Journal of separation science》;20140228;第37卷(第4期);第368-375页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104224739A (zh) | 2014-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5775464B2 (ja) | 非晶質cddo−meを含有する遅延放出性経口投薬組成物 | |
CN104434805B (zh) | 一种替格瑞洛固体分散体及其制备方法 | |
AU2009279520A1 (en) | Pharmaceutical formulations of an HCV protease inhibitor in a solid molecular dispersion | |
TW201446286A (zh) | 抗病毒化合物之固態分散調製劑 | |
Visser et al. | Inulin solid dispersion technology to improve the absorption of the BCS Class IV drug TMC240 | |
CN105456270A (zh) | 一种二肽基肽酶ⅳ抑制剂药物组合物、其用途及其制备方法 | |
CN107397732A (zh) | 提高依折麦布片溶出度的方法 | |
CN103356616A (zh) | 一种含有比拉斯汀的药物组合物及其制备方法 | |
CN107913256A (zh) | 一种治疗肺动脉高压的马西替坦口腔崩解片及其制备方法 | |
CN104622836B (zh) | 索非布韦包衣片剂及其制备方法 | |
CN104224739B (zh) | 一种以恩替卡韦为主药成分的口服固体组合物 | |
WO2014125352A1 (en) | Pharmaceutical compositions comprising tadalafil | |
CN107334772B (zh) | 一种抗逆转录病毒药物组合物 | |
CN107998097B (zh) | 一种含奥美沙坦酯的片剂及其制备方法 | |
CN110063944B (zh) | 一种苯磺酸左旋氨氯地平阿托伐他汀钙片及其制备方法 | |
CN105828827A (zh) | 一种含他克莫司的药物组合物及其制备方法 | |
CN105902507A (zh) | 一种乙磺酸尼达尼布制剂及其应用 | |
CN104800184A (zh) | 琥珀酸呋罗曲坦缓释剂片 | |
CN101108872A (zh) | 植物生物碱提取物及其制剂与用途 | |
CN103284953B (zh) | 一种双环醇固体制剂及其制备方法 | |
CN103751109A (zh) | 替格瑞洛干混悬剂及其制备方法 | |
CN101108224A (zh) | 一种植物生物碱提取物及其制剂与用途 | |
CN1899275B (zh) | 大黄酸或大黄酸类化合物的复合物在制备治疗骨关节炎药物中的应用 | |
CN102670535B (zh) | 一种盐酸氯吡格雷片 | |
CN104288141B (zh) | 一种辛伐他汀固体药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Inventor after: Liu Chong Inventor after: Zhao Jiamin Inventor before: The inventor has waived the right to be mentioned |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20161223 Address after: North Street house 261000 Shandong city of Weifang province Kuiwei District No. 264 Applicant after: Liu Chong Address before: 301700 Tianjin Guangyuan Wuqing Development Zone Wuqing Road on the south side of the Swan Garden District Building 8 Room 703 Applicant before: Li Baoqi |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180612 Address after: 226500 No. 999 Wanshou South Road, Chengnan street, Rugao City, Nantong, Jiangsu (room 3A08-26, 8 building, Rugao hi tech Zone) Patentee after: Jiangsu hundred sword Pharmaceutical Technology Co., Ltd. Address before: 261000 264 North Palace Street, Kuiwei District, Weifang, Shandong. Patentee before: Liu Chong |